Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

ACCELERO: Ph1b/2 Study of Disitamab Vedotin in HER2 Breast Cancer

Phase II Clinical Trial

A PHASE 1B/2 OPEN-LABEL MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER.(C5731006/SGNDV-006)

Indication: Breast Cancer

Trial Number: 06966453

Trial Status: Call Proj Mgr

Learn more about this clinical trial.

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use